Analytical Report
Almaty 2015
Accessed: 26.09.2019
January - December 2019
First published April 2020
• Between January to December 2019, an estimated 8.58 million people were reached at least once with some form of humanitarian assistance, including over
91,000 people through three inter-agency convoys, two to Rukban and one to Menbij. On ...average, 3.4 million people received some form of humanitarian
assistance on a monthly basis.
• Response efforts have seen a 39% increase in December compared to November with around 4.88 people reached.
• More than a third (38.5%) of this response was delivered to areas of most acute need (which host an estimated 40% of people in need); 25.3% of the response
was delivered to areas with major needs (which host an estimated 42% of people in need); and 36.2% of the response was delivered to other areas of lower
severity and include life-saving activities (e.g.: vaccination campaigns, nutrition screening and water provision) to reduce excess morbidity and mortality.
more
This document provides guidance on the implementation of the shielding approach in camps and camp-like settings for refugees and internally displaced persons. It is intended for the displaced community itself, humanitarian actors and camp coordination / management authorit...ies.
more
This document provides guidance on the implementation of the shielding approach in urban areas in LICs and crisis-affected regions. It is intended for the community itself, national and local governance institutions, and humanitarian and development actors operating in the country.
Módulo 9
Planificación estratégica
Julio del 2017
Módulo 9: Planificación estratégica. La OMS recomienda ofrecer la PrEP a las personas con un riesgo significativo de contraer la infección por el VIH, por lo que este módulo ofrece orientación de salud pública para los encargados de ...tomar decisiones sobre cómo priorizar los servicios, con el fin de llegar a quienes se pueden beneficiar más de la PrEP, y sobre los entornos donde los servicios de PrEP podrían ser más costo-efectivos.
more
Global Plan to end TB 2016-2020
This is an abridged version of the 2019 Standards containing the evidence-based recommendations most pertinent to primary care. The tables and figures have been renum-bered from the original document to match this version. The complete 2019 Standards of Care do...cument, including all supporting references, is available at professional.diabetes.org/standards.
This is an abridged version of the American Diabetes Association’s Standards of Medical Care in Diabetes—2019. Diabetes Care2018;42(Suppl. 1):S1–S194. The complete 2019 Standards supplement, including all supporting references, is available at professional.diabetes.org/standards.
more
The World Cities Report 2020 shows that the intrinsic value of sustainable urbanization can and should be harnessed for the wellbeing of all. The Report provides evidence and policy analysis of the value of urbanization from an economic, social and environmental perspective, including the unquantifi...able value that gives cities their unique character; and also explores the role of innovation and technology, local governments, targeted investments and the effective implementation of the New Urban Agenda in fostering the value of sustainable urbanization.
Please download the whole report in different languages here: https://reliefweb.int/report/world/world-cities-report-2020-value-sustainable-urbanization
more
Country Strategic Plan Evaluations (CSPEs) encompass the WFP strategy and entirety of WFP activities during a specific period. Their purpose is twofold: 1) to provide evaluation evidence and learning on WFP's performance for country-level strategic decisions, specifically for developing the next Cou...ntry Strategic Plan (CSP) and 2) to provide accountability for results to WFP stakeholders. These evaluations are mandatory for all CSPs and are carried out in line with the WFP Policy on Country Strategic Plans and the WFP Evaluation Policy.
more
Research Article
PLOS ONE | https://doi.org/10.1371/journal.pone.0192791 February 15, 2018
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported ...serious adverse events (SAEs).
more
Principles and Target Product Criteria. Roadmap January 12, 2015